Global Cell Expansion Market - By Product: Consumables (Media, Reagents, Sera), Instruments (Bioreactors, Cell Culture Systems), Accessories & Supporting Equipment; By Cell Type: Human Cells (Stem Cells, Differentiated Cells), Animal Cells; By Application:Regenerative Medicine, Stem Cell Research, Cancer Research and Immunotherapy, Biopharmaceutical Manufacturing; By End User: Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Hospitals & Clinical Laboratories, Cell Banks; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
1 | Market Overview
The global cell expansion market is experiencing significant growth, driven by increasing demand for regenerative medicine, stem cell therapies, and cancer immunotherapy. Cell expansion technologies facilitate the production of large quantities of cells for research, clinical trials, and therapeutic uses.
Increasing investment in cell-based research, the rising prevalence of chronic diseases, and advancements in bioreactor technologies are driving market growth. The emergence of allogeneic cell therapies, CAR-T cell production, and improvements in 3D cell culture systems further boost demand.
2 | Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
13.1 |
Historical benchmark |
|
2024 |
20.5 |
Five-year CAGR 9.4% |
|
2031 |
44.6 |
Seven-year CAGR 11.6% |
The market is expected to more than double by 2031, supported by increasing clinical trials, growth in regenerative therapies, and rising biomanufacturing demand.
3 | Key Market Drivers
4 | Market Challenges
5 | Competitive Landscape
The cell expansion market is somewhat consolidated, led by major biotechnology equipment suppliers, with emerging startups focused on niche innovations.
Market Share Estimates (2024):
|
Company |
Estimated Market Share |
Key Products |
|
Thermo Fisher Scientific |
20% |
Nunc™ cell culture products, Gibco™ media, bioreactors |
|
Danaher (Cytiva) |
17% |
Xuri™ cell expansion systems |
|
Merck KGaA (MilliporeSigma) |
15% |
Mobius® bioreactors, media, and reagents |
|
Sartorius AG |
12% |
BIOSTAT® STR bioreactors |
|
Others (Lonza, Eppendorf, Corning, regional players) |
36% |
Niche solutions and custom bioreactor systems |
6 | Market Segmentation
By Product:
By Cell Type:
By Application:
By End User:
By Region:
7 | Strategic Outlook
The future of the cell expansion market depends on closed automated systems, AI-driven bioprocess monitoring, and modular GMP-compliant manufacturing facilities. Growth will speed up through expansion into emerging markets and partnerships among biotechs, CROs, and CDMOs.
Need help?
Chat with our team in a minute.